Boston University
Pathophysiological mechanisms linking obstructive sleep apnea to cardiovascular disease
Abstract
dc:description.abstractIn addition to being one of the most common chronic sleep disorders in the world, covering an estimated 936 million people, obstructive sleep apnea (OSA) is increasingly known to also be a large independent cardiovascular risk factor. Although well-known and highly clinically relevant, OSA remains substantially underdiagnosed, especially in patients with established cardiovascular disease (CVD). Within this thesis a complete overview is given of the pathophysiological processes that lead to cardiovascular damage in OSA with focus on epidemiology, experimental studies with mechanistic approaches and the most prominent clinical trials. The basic pathophysiology of OSA is recurrent partial or complete collapse of the upper airway during sleep, which causes intermittent hypoxia and hyperoxia, sleep fragmentation, significant intrathoracic pressure changes, and sympathetic nervous system (SNS) activation. Together, these acute events trigger a complex pathophysiological cascade of oxidative stress, systemic inflammation, endothelial and autonomic dysfunction. This cascade promotes a pro-thrombotic state and drives the progression of CVD. In this thesis, the cardiovascular effects of OSA studied include systemic hypertension (HTN), coronary artery disease (CAD) and atherosclerosis, heart failure (HF), stroke, cerebrovascular disease, and cardiac arrhythmia particularly atrial fibrillation (AF). Results are summarized and reviewed by some of the most important epidemiological cohort studies (WSCS: Wisconsin Sleep Cohort Study; and SHHS: Sleep Heart Health Study) and large randomized clinical trials (SAVE: Sleep Apnea Cardiovascular Endpoints; ISAACC: Impact of Sleep Apnea Syndrome in the evolution of Acute Coronary Syndrome;, and RICCADSA: Randomized Intervention with CPAP in the evolution of Acute Coronary Syndrome). This is followed by review of the effect of continuous positive airway pressure (CPAP) therapy on cardiovascular risk from a meta-analysis; and the role of alternative treatment approaches, including individual patient data (IPD) meta-analysis which was conducted by Sanchez-de-la-Torre and colleagues on the treatment effect of CPAP therapy. The remainder of the thesis explores the hypothesis that OSA is modifiable and a cardiovascular risk factor whose interrelated pathophysiological mechanisms contribute to the residual cardiovascular risk observed in patients, despite optimal control of other risk factors. The clinical implications of early diagnosis and management of OSA, along with estimates of its effects on cardiovascular morbidity and mortality, are discussed in detail. Lending to ambitious future research directions, including the potential for therapeutic interventions to eventually target particular phenotypic subgroups, as well as developments on improving the effective use of hypoxic burden as a measure of OSA illness severity, and longitudinal studies in the population for primary prevention.
Degree
thesis:*- Name thesis:degree_name
- Master of Science
- Level thesis:degree_level
- masters
- Discipline thesis:degree_discipline
- Medical Sciences
- Grantor
- Boston University
- Year dc:date.issued
- 2026
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Khan, Ayman
- Advisors dc:contributor.advisor
-
- Carnevale, Katelyn J.
- Young, Aaron W.
Subjects
dc:subject × 3Rights
- Language dc:language.iso
- en_US
Identifiers
dc:identifier.*- Handle dc:identifier.uri
- https://hdl.handle.net/2144/53483